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Australian women’s experiences of
the subdermal contraceptive implant:
A qualitative perspective
Kumiyo Inoue, Marguerite Kelly, Alexandra Barratt, Deborah Bateson, Alison Rutherford, Kirsten I Black, Mary Stewart, Juliet Richters

Background
The number of prescriptions for contraceptive implants has
steadily increased in Australia, but implant use is still low.

Objectives
The objectives of the study were to describe women’s nuanced
responses, and characterise their multidimensional and
complex reasons for (dis)continuing use of the contraceptive
implant.

Method
A descriptive qualitative approach was used for this study. A
larger qualitative study using in-depth, open-ended interviews,
conducted in New South Wales between 2012 and 2013 with
94 women aged 16–49 years who had used contraception,
included 10 interviews containing accounts of implant use. The
10 interviews were analysed thematically in the present study.

Results
The three main themes analysed from the 10 interviews were
perceived benefits, undesirable experiences and perseverance.

Discussion
The participants were well informed about the benefits of the
implant. Many persevered with it for a significant period of time
before discontinuing it, despite experiencing side effects such
as bleeding or mood changes. A decision to discontinue was
often only made after an accumulation of multiple side effects.
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ong-acting reversible contraceptives (LARCs), including
the subdermal implant (etonogestrel, sold in Australia
under the brand name Implanon), are highly effective and
safe, and are thus recommended by health professionals as
suitable for women of all ages.1,2 The prescription rate of the
implant has increased steadily in Australia,3 but its use is still
lower than in other comparable countries.1
Approximately half of the women who commenced using
the implant in Australia4,5 and the UK6 discontinued it within
two years. Major reasons for discontinuation are discontent
with bleeding patterns,7 abnormal bleeding5,8 and mood
changes.4 However, women report a wider range of reasons for
discontinuation that are not always captured by side-effect data
in clinical studies.9
This is not surprising because contraceptive research often
uses outcome variables that may mask women’s points of
view by categorising responses seen as clinically irrelevant as
‘other’.10 For this reason, a qualitative approach is recommended
to gain an accurate understanding of women’s views.9,10 A
qualitative study11 of young women aged 16–22 years in the
UK acknowledged the complexities involved in the decision
to discontinue the implant. Furthermore, a recent Australian
study identified that 40% of women changed contraceptive
method for non-contraceptive reasons.12 Examination of clinical
side effects alone fails to adequately engage with women’s
actual experiences and the subtle nuances that ‘tip’ them into a
discontinuation decision.
An in-depth qualitative approach to understanding the
experiences of Australian women who have used the implant
is lacking in research to date. This article describes the lived
experiences of 10 Australian women who have used the
implant, some multiple times. The study illuminates women’s
nuanced responses, and characterises their multidimensional
and complex reasons for (dis)continuing the implant.

© The Royal Australian College of General Practitioners 2016
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Methods
A descriptive qualitative methodology
was used for this study. We sought to
keep as close to the data as possible and
report in-depth, direct descriptions of the
participants’ experiences.13 The analysis
specific to this article was a subset of
a data analysis (n = 10) from a larger
qualitative study into Australian women’s
contraceptive understandings and
experiences (CUE study, https://research.
unsw.edu.au/projects/contraceptionunderstandings-and-experiencesaustralian-women). Detailed information
about methods and procedures, including
recruitment, ethical consideration and data
analysis/management can be found in our
published companion paper.14
The prepared interview prompts that
are specific to the implant are presented
in Box 1. These were rarely needed in
the interviews with implant users, in
which participants responded to general
open-ended questions. The de-identified
transcripts were thematically analysed
by the first and second authors using the
procedure reported by Braun and Clarke.15
Three themes were saturated in this
subset (n = 10) of data.
The project was approved by the
Human Research Ethics Committee
of the University of New South Wales
(reference HC11504).

Results
The women often used the term ‘rod’, or
the brand name ‘Implanon’, to describe
the implant. In this paper, we refer to
participants who have used a subdermal
implant at any time (n = 10) as ‘implant
users’, and those who were using an
implant at the time of the interview as
‘current users’. Demographic information
on the participants in this study is shown

in Table 1. Of the 10 participants, two were
still using the implant. The remaining eight
gave reasons for discontinuation that are
similar to those reported in the literature,
such as bleeding and mood-related issues,
but the interviews illuminate the complex
interplay of multiple factors.
Women sometimes tolerated the side
effects from the implants for many years
before they discontinued the method.
The eight women who had discontinued
using the implant had done so after
different periods of time and for various
reasons, and were not necessarily
dissatisfied with it overall. Indeed, some
of these women were satisfied with the
implant for a period of time. The three
saturated themes discussed in this paper
are: perceived benefits, undesirable
experiences and perseverance.

Perceived benefits
All of the participants interviewed were
well informed about the benefits of
the implant that are often referred to in
educational material, such as the low
cost (specified by holders of a healthcare
concession card), convenience (no daily
action required), long-term effectiveness
and possibility of managing heavy bleeding.
Quite often, the prospect of multiple
benefits was considered to be attractive.
I’ve just had my third Implanon taken
out. So it’s been nine years. I think I
got one taken out early, but yeah, nine
years of Implanon. I just loved the
convenience of that and the price …
– Chloe (30s)
The possibility of fewer or lighter periods,
or the absence of bleeding, was viewed
positively by participants, and they
enjoyed the convenience of this and
realising that they saved on the cost of
sanitary products. However, the impact of

Box 1. Interview prompts specific to the implant
• Have you heard of the implant (or a bar inserted into your arm)?
• Tell me anything you know about the implant.
• Could you tell me about your experience with using the implant?
• Do you think any contraceptive methods have affected your sex life? What about the implant?

© The Royal Australian College of General Practitioners 2016

the implant on bleeding was not uniform
between participants and varied for
individual participants with each different
implant used.
The recognition of benefits is not
necessarily shared between participants
and health practitioners. One current user
expressed a very positive attitude towards
the implant. She described her experience
as ‘eye-opening’ and ‘life-changing’.
However, she said that it was a long time
before she encountered a doctor who
took her history of migraines into account
and suggested that the implant, which
did not contain oestrogen, would be the
best option for her. The participant spoke
of the improvements the implant brought
to her life and disclosed her unsatisfactory
experiences with previous doctors
whom she reported had prescribed the
contraceptive pill without thoroughly
taking her medical history into account.

Undesirable experiences
General comments such as ‘the implant
did not agree with me’ or ‘I did not like it’
were often used to summarise multiple
bodily changes that led to discontinuation
of the contraceptive implant. For some
participants, the implant brought
unpleasant experiences, including painful
insertion and removal, and changes in
mood and bleeding patterns. Similarly
to the results of existing studies,14,16–20
constant or irregular bleeding was
described as problematic and was given
as a reason for removal of the implant by
most of the participants who discontinued
using it.
All of the implant users in our study
were aware of the absence of bleeding
as a possible result of implant use. In line
with the study by Darney et al,21 a lack of
bleeding was considered by some to be a
non-contraceptive benefit and by others to
be ‘unnatural’ but tolerable. The nature of
the vaginal bleeding itself was, for some
participants, a measure of the bodily
effects of the implant.
I had an Implanon for three years –
the first one was three years, got it
changed. No dramas at all. I had very
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few bleeds. But always felt kind of
bloated and a bit tired. And then maybe
halfway through the second one … I’d
bleed for six weeks non-stop and then
I’d have two weeks off. And it got really
kind of intense and very painful. And
the consistency got really quite dark
and really heavy, and very sort of old
and nasty, I guess. – Mia (20s)

The impression from our data, that
bleeding and mood-related side
effects are the two main triggers
for discontinuation of the implant, is
consistent with other studies.4,7
The participants also described a
variety of other reactions to the implant,
such as headaches, pain (at various sites),
nausea, bloating, tiredness, and dramatic

mood changes and swings. Some
concerns were not clearly articulated in
terms of clinical symptoms. Statements
such as ‘I found it difficult to lose weight’,
‘I was emotional’, ‘I was cranky’, ‘I was
mean’, ‘I felt angry’ and ‘I was depressed’
were used by participants to describe
how they felt when they were using the
implant.

Table 1. Demographic information of the 10 women
Number of
children;
relationship
status

Current
contraception
and history of
implant use
(number of times)

Reasons for
discontinuation, if
discontinued (or
scheduled to do so)

Pseudonym
and age group

Ethnicity*

Location†

Zara (40s)

Anglo-Celtic

Urban

No children; in a
relationship

Implant (1)

N/A

Grace (40s)

Anglo-Celtic

Regional

Three children; in a
live-in relationship

Implant (3)

N/A

Ella (20s)

Aboriginal and
Torres Strait
Islander

Rural

Two children; in a
live-in relationship

Implant (3)

Continuous bleeding

Naomi (30s)

Anglo-Celtic

Urban

Two children; not in
a relationship

Safe period
(checking ovulation);
used implant for four
years (2)

Perception that
hormones and
chemicals are not
good for health

Charlotte (30s)

Aboriginal and
Torres Strait
Islander

Regional

Two children; in a
live-in relationship

Tubal ligation; used
implant for ‘a few’
years (1)

Mood changes pointed
out by others

Mia (20s)

Anglo-Celtic

Regional

No children; not in
a relationship

Condoms (no
more hormonal
contraception);
used implant for
about 4.5 years (2)

Bleeding irregularity

Chloe (30s)

Anglo-Celtic

Regional

No children; in a
live-in relationship

Hormonal IUD; used
implant for nine
years (3)

Bleeding problems

Ruby (30s)

Anglo-Celtic

Urban

Four children; not
in a relationship

Withdrawal; used
implant for <1 year (1)

Constant bleeding

Sylvia (20s)

Anglo-Celtic

Rural

Two children; in a
live-in relationship

Not taking
contraceptives
(pregnant); used
implant for about
six months (1)

Intermittent bleeding
and mental health
effects (anxiety and
depression)

Hannah (20s)

Anglo-Celtic/
Aboriginal and
Torres Strait
Islander

Rural

No children; in a
live-in relationship

Contraceptive pill;
length of time each
implant was used is
unknown (3)

Three different side
effects each time
(bleeding, extreme
mood changes, asthma)

*Ethnicity was disclosed by women themselves
†
‘Urban’ refers to the state capital, Sydney; ‘regional’ refers to other large towns and cities; ‘rural’ refers to smaller rural towns and localities
IUD, intrauterine device
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Quite often, participants were unsure
whether their experience resulted
from the implant or something else.
Hoggart et al11 found that women did not
necessarily consider specific changes
in their body or emotions to be directly
connected with the implant.
Sometimes, mood swings were
recognised by the implant users
themselves, but not always. Charlotte
(30s), who described the implant
positively as an ‘easy and secure method’,
eventually decided to stop using it
because her mother and others pointed
out mood changes that she had never
recognised herself. She stated:
I personally thought it was okay, but
others around me thought that my
moods had … just mood swings, you
know, and they just thought, 'You’re
not right' … especially my mum.
– Charlotte (30s)
Negative attitudes towards the implant
only came about retrospectively for one
participant, who spoke of the pain she
experienced when it was removed and
her subsequent struggle with infertility.
Another participant, who had positive
attitudes, described not feeling entirely
herself and having subtle concerns that
she was unable to pinpoint, saying ‘I
always felt something, but I did not know
how to describe it’.
Bleeding and emotional problems
affected participants personally, as well as
affecting their relationships and sex lives.
Some participants explained that they
‘lost [their] sex life’ because of constant
bleeding while using the implant. They
described a reduced desire for sex as a
result of physical and emotional changes,
and instability of mood.
So I left it in for a year, and I’d say out
of that year, I probably had one month
of not bleeding. That was a very tough
year ’cause I was with a partner then
and he kept getting very, very cranky
because I was always bleeding. Just
always. Even if it was just a little bit.
Sometimes it was heavy, sometimes it
wasn’t. It just, it was just not working
… that was awful. It didn’t make me

© The Royal Australian College of General Practitioners 2016

feel anything – like I didn’t feel sick or
anything – but just the whole sex life
and the fact that I was always having
to wear pads, and yeah, just yuck. I just
couldn’t do anything. I… couldn’t go
swimming. I couldn’t just enjoy myself.
So then I had it taken out. – Ruby (30s)
It is not clear from this extract whether
Ruby lacked interest in sex while she
was bleeding, or whether she and/or
her partner assumed that sex during
menstruation was not acceptable or
preferable. Women’s beliefs about sexual
intercourse during bleeding are influenced
by complex social, physical, psychological
and interpersonal constraints, and
behavioural expectations.22 The literature
suggests that bleeding can affect the
sexual behaviour of a woman and her
partner.23–25 It is also possible that irregular
bleeding is easier for women to discuss
in a medical consultation rather than any
sexual issues associated with it.

Perseverance
Some participants persevered with one or
more implants, tolerating several physical
and emotional changes. Their decision to
discontinue the use of the implant was
often triggered by intolerable bleeding
or mood changes, but was often the
culmination of many undesirable side
effects.
Sylvia (20s) persevered through multiple
side effects, but reported that it was
intermittent bleeding that eventually
prompted her to discontinue the implant.
As the interview progressed, she spoke
of changes in her cycle as well as
psychological, openly expressing her fear
about the bodily effects of the implant.
Sylvia claimed that she would never use
the implant again or recommend it to
anyone. She described the implant as:
An evil little bar sending negativity …
a cranky little bar in my arm … the
Implanon. Because it affected so much
that I sort of got a bit worried about
what it was actually doing to my body.
– Sylvia (20s)
Sylvia mentioned that the mental health
issues she experienced while using the

implant became clearer after its removal:
It affected my head as well … I sort of
got to the point where I couldn’t wait to
actually get it taken out. … and then I
found that, after I got it taken out, sort
of a lot of things started levelling back
out again. – Sylvia (20s)
Ella (20s) disclosed that she was planning
to have her third implant removed early
because of bleeding. She continued with
the first and second implants despite
recognising emotional changes such as
feeling cranky, angry and sad. Her third
implant was inserted after a break to ‘clean’
her body from hormones, even though
she was not convinced that it was suitable
for her, given the mood changes from
the first two. Five months of ‘constant
bleeding’, nausea, feeling overly emotional
and gaining weight while using her third
implant triggered her decision to have the
implant removed.
One participant persisted with three
implants before deciding that it was
not a suitable method of contraception
for her. Hannah reported her reasons
for prematurely discontinuing each of
her three implants. She recounted her
experiences of continuous bleeding
for six months with her first implant,
extreme mood changes with her second
and asthma with the third. Hannah was
adamant that all of these experiences
were associated with the implants and
explained that she was able to confirm
the differences between what was normal
and abnormal each time the implant was
removed. Eventually, she came to the
conclusion that the design of the implant
itself was the problem.
To have it go wrong in so many different
ways three different times is, it just
makes you think well maybe it needs
redesigning, rethinking. – Hannah (20s)
In line with other studies,7,11 we found that
a single negative experience was unlikely
to trigger discontinuation of the implant,
and that some women persevered with
it despite experiencing ongoing side
effects. Our findings address subtle
and apparently less significant changes
experienced by participants, some of
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which were not even recognised by the
women themselves. Some participants
in our study initially reported one side
effect or made a short statement such
as ‘I failed with the implant’ or ‘it did not
work for me’. However, as the interview
progressed, or clarification was sought
by the interviewer, they spoke of other
changes in their body, and quite often
more specific and detailed stories
subsequently emerged.

Discussion
This article reports the only study in
Australia to date that captures qualitative
data about users’ perception of the
contraceptive implant, rather than simply
outlining reasons for discontinuation.
It provides an in-depth qualitatively
approached understanding of the
experiences of Australian women who
have ever used the implant. It also
explores the imagery women use to
describe their experiences, which may
be helpful for doctors seeking to offer
information and ongoing support to
women using this method.
The negative aspects of the
participants’ experiences with the implant
were more prominent in their own
accounts. However, some participants
who were unhappy with their previous
choice of contraceptive found the implant
to be a suitable method that improved
their lives. The accumulation of multiple
negative side effects over time led some
women to discontinue the implant.
Interestingly, these participants often
persevered with it for a significant period.
We identified three possible contributors
to this finding, which warrants further
investigation.
First, women may not have drawn
a connection between the perceived
changes in their body or emotions and the
implant. Second, women were not always
able to clearly describe the changes they
perceived, either when they were using
the implant or after its removal. Third,
women could often only be ‘conclusive’
about their impression of the side effects
of the implant after discontinuation.
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Many of the participants in this study did
not raise their issues with a doctor until
they had already decided to discontinue
the implant. Access to well-informed
healthcare professionals, and proactive
encouragement at the time of insertion
about seeking advice for any unwanted
side effects as they arise, may support
improved satisfaction for women. Expertly
moderated user–provider internet forums
on topics related to the implant may also
be useful to give women an opportunity to
share their experiences, and for clinicians
to be aware of issues raised by women
using this method of contraception.

Limitations and strengths
This qualitative study does not aim to be
representative of all women’s views on the
contraceptive implant, but rather to capture
themes among users who either continued
or discontinued the method. As we did not
specifically target women who had used
the implant, the number of participants
was small. There was also a possibility of
negative recall bias among women who
had an implant removed, and who may
subsequently equate it with symptoms or
other changes in their life that may or may
not have been associated with its use.
A cohort of current users may provide
more positive perspectives. Baumeister
et al found that people tend to process
negative information more thoroughly than
positive information, and that negative
events tend to be more memorable.26
Overall, the negative aspects of the
participants’ experiences with the implant
were more prominent in their accounts,
which may be related to there being
only two current and eight previous
users who recounted their experiences
retrospectively.

Implications for general practice
This study suggests that GPs need to
better understand women’s perceptions
about the implant and incorporate these
understandings into their contraceptive
consultations.
The study also indicates that some
women may persevere through

multiple perceived side effects from the
contraceptive implant before deciding
to have it removed. Health professionals
need to be aware that women will not
necessarily volunteer information about
side effects unless specifically asked,
particularly if it relates to bleeding
interfering with sexual activity.
There are strategies that health
professionals can use to assist women
with troublesome bleeding associated with
the contraceptive implant,27 and it may be
beneficial to discuss these at initiation to
potentially circumvent perseverance until
the point of discontinuation. Nevertheless,
when advising about the potential side
effects, health practitioners should
reassure women that the method is
reversible, and that early removal might
be appropriate if troublesome side effects
persist. Further research following women
using the implant prospectively would
be useful in shedding further light on
women’s experiences of this important
LARC method to best support its informed
choice and ongoing use.
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